News Alert

HHS to Issue Guidance on 340B Rebates, IRA Interaction Within 30 Days

HHS plans to release stakeholder guidance on 340B rebates in 30 days.
The U.S. Department of Health and Human Services (HHS) plans to release guidance within 30 days on 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hawaii Legislature Passes Amended 340B Contract Pharmacy Access Bill with Limited Reporting Requirements

On April 30, both chambers of the Hawaii legislature passed an amended 340B contract pharmacy access bill.
Both chambers of the Hawaii Legislature yesterday approved a 340B contract pharmacy access bill with provider reporting requirements following weeks [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sumitomo Exempts Four More States From 340B Contract Pharmacy Restrictions, GSK Exempts Nebraska, Utah

Sumitomo Pharma America has announced exemptions to its contract pharmacy restrictions for 340B covered entities in Nebraska, North Dakota, South Dakota and Utah.
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State 340B Contract Pharmacy Lawsuit Roundup: New Filings in Utah

Key briefs were filed recently in state contract pharmacy litigation in Utah.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Federal Judge Grills Both Sides in Key Hearing on 340B Rebate Dispute

A hearing on five drug industry 340B rebate lawsuits took place April 29 in the U.S. District Court for the District of Columbia.
A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Holds High-Stakes Hearings Today on Five Drug Industry 340B Rebate Lawsuits

U.S. District Judge Dabney Friedrich of the District of Columbia is presiding over five April 29 hearings over drugmaker 340B rebate lawsuits. She previously largely sided with Novartis and United Therapeutics in a separate case on drugmaker contract pharmacy restrictions.
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Audits Find Two Drugmakers Overcharged for 340B Drugs, Driving Calls for More Drug Industry Oversight 

HRSA released the results of its first two drugmaker audits of 2025 this month.
Recent Health Resources and Services Administration (HRSA) audits found that two drugmakers overcharged covered entities for their 340B drugs, fueling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California, Texas, Oklahoma Advance 340B Contract Pharmacy Access Bills with Key Amendments

California lawmakers recently advanced a 340B contract pharmacy access bill through committee but amended it to exclude 340B hospitals.
State legislators in California, Texas and Oklahoma have recently advanced 340B contract pharmacy access bills with amendments that in some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Tightens 340B Contract Pharmacy Restrictions, Biogen Exempts Nebraska From Its Restrictions Policy

Japanese pharmaceutical giant Takeda recently announced changes to its 340B contract pharmacy restrictions.
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live